TEK and cancer: Our evolution of Tie2 ectodomain to discriminate between Ang1 and Ang2 has created an Ang2 ligand trap with potential for blocking the deleterious effects of the elevated Ang2 in conditions such as vascular inflammation, sepsis, and cancer.